Home › Metabolic › Retatrutide (10mg)
Metabolic Research Peptide
GLP-1 / GIP / Glucagon triple-receptor agonist · Research-grade, Australia
In stock · dispatched Australia-wide
View & buy on store →Retatrutide (development code LY3437943) is a synthetic triple-agonist peptide that acts on three metabolic receptor targets at once: the glucagon-like peptide-1 (GLP-1) receptor, the glucose-dependent insulinotropic polypeptide (GIP) receptor, and the glucagon receptor. This combined single-molecule activity distinguishes it from earlier single- and dual-agonist research peptides.
Within the research community, Retatrutide has drawn substantial interest as a subject for studying metabolic regulation, energy homeostasis, insulin signalling, and adipose-tissue metabolism in pre-clinical and laboratory models. It is supplied by Vital Research Labs strictly as a reference compound for in-vitro laboratory investigation.
In research contexts, Retatrutide is characterised by its simultaneous activity across three receptors involved in metabolic signalling:
| Compound | Retatrutide |
|---|---|
| Synonym | LY3437943 |
| Category | Metabolic |
| CAS Number | 2381089-83-2 |
| Form | Lyophilised powder |
| Appearance | White to off-white solid |
| Quantity | 10 mg per vial |
| Purity | 99.49% (this batch) |
| Batch | CS-re10920 |
| Analytical methods | HPLC (purity), mass spectrometry (identity) |
| Solubility (research) | Reconstitutes in bacteriostatic or sterile water |
Batch-specific analytical values are recorded on the Certificate of Analysis supplied with the compound.
Retatrutide is supplied as a lyophilised (freeze-dried) powder. For research handling, the powder is typically reconstituted with bacteriostatic water; the exact volume depends on the concentration a given research protocol calls for. Our reconstitution calculator can be used to work out volumes for a target research concentration. Handle under appropriate laboratory conditions and avoid repeated freeze–thaw cycles of the reconstituted solution.
Every batch supplied by Vital Research Labs is analysed by an independent third-party laboratory. Purity is confirmed by high-performance liquid chromatography (HPLC) and identity by mass spectrometry (MS). This batch is verified at 99.49% purity, and a Certificate of Analysis is available for the batch so researchers can verify exactly what they are working with.
Retatrutide is dispatched from within Australia to Australian research customers, packaged discreetly and appropriately for a lyophilised research compound. Orders are processed on receipt of payment via bank transfer.
Yes. Vital Research Labs supplies research-grade Retatrutide (10 mg) to Australian research customers, dispatched domestically. It is provided strictly for in-vitro laboratory research and is not for human or veterinary use.
This batch is verified at 99.49% purity by third-party analytical testing (HPLC for purity, mass spectrometry for identity). A Certificate of Analysis is available for the batch.
Each batch is analysed by an independent third-party laboratory using HPLC to confirm purity and mass spectrometry to confirm identity. Batch-specific values are recorded on the Certificate of Analysis.
The lyophilised powder is stored at -20 °C, protected from light and moisture. Once reconstituted for research, it is kept at 2–8 °C and typically used within 28 days.
No. Retatrutide supplied by Vital Research Labs is intended strictly for in-vitro laboratory research and development. It is not a medicine or therapeutic good and is not for human consumption, veterinary use, or clinical application.